These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22484396)

  • 1. Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety.
    Mikel C; Pesce AJ; Rosenthal M; West C
    Clin Chim Acta; 2012 Aug; 413(15-16):1199-202. PubMed ID: 22484396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
    Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
    Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of Triage for benzodiazepines: urine analysis of the dose of therapeutic cases.
    Kurisaki E; Hayashida M; Nihira M; Ohno Y; Mashiko H; Okano T; Niwa S; Hiraiwa K
    J Anal Toxicol; 2005 Sep; 29(6):539-43. PubMed ID: 16168176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS analysis of 13 benzodiazepines and metabolites in urine, serum, plasma, and meconium.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2010; 603():89-105. PubMed ID: 20077062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced urine toxicology testing.
    Tenore PL
    J Addict Dis; 2010 Oct; 29(4):436-48. PubMed ID: 20924879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct urine analysis for the identification and quantification of selected benzodiazepines for toxicology screening.
    Karampela S; Vardakou I; Papoutsis I; Dona A; Spiliopoulou C; Athanaselis S; Pistos C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 902():42-6. PubMed ID: 22790390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB; Floyd D; Dasgupta A
    Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test.
    Bertol E; Vaiano F; Borsotti M; Quercioli M; Mari F
    J Anal Toxicol; 2013; 37(9):659-64. PubMed ID: 23943436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid screening for 67 drugs and metabolites in serum or plasma by accurate-mass LC-TOF-MS.
    Marin SJ; Hughes JM; Lawlor BG; Clark CJ; McMillin GA
    J Anal Toxicol; 2012 Sep; 36(7):477-86. PubMed ID: 22802572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzodiazepine analysis by an improved LC-MS/MS method illustrates usage patterns in Washington State.
    Keung Chan K; Moore AJ; Hoofnagle AN; Baird GS; Liao HC
    Clin Chim Acta; 2023 Mar; 543():117274. PubMed ID: 36934953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of liquid chromatography-tandem mass spectrometry (LC-MS/MS) to test blood and urine samples for the toxicological investigation of drug-facilitated crimes.
    Deveaux M; Chèze M; Pépin G
    Ther Drug Monit; 2008 Apr; 30(2):225-8. PubMed ID: 18367985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.